Latest News

syringe and doctor | Image credit: New Africa - stock.adobe.com
Biosimilars Council: PBM Rebate Schemes Cost Americans, Payers $6 Billion

April 10th 2024

A report from the Biosimilars Council evaluating IQVIA data found that rebate schemes orchestrated by pharmacy benefit managers (PBMs) are costing US patients and payers billions of dollars by suppressing biosimilar adoption.

biosimilars check-in banner
Biosimilar Business Recap: BI Layoffs; Teva, mAbxience Partnership; Phase 3 Keytruda Biosimilar Trial

April 8th 2024

data | Image credit: apinan - stock.adobe.com
Meta-Analysis Confirms Similar Safety, Efficacy Between Adalimumab Biosimilars, Humira

April 6th 2024

injectable pen | Image credit: Orawan - stock.adobe.com
The Totality of Evidence Supporting Adalimumab Biosimilar AVT02

March 30th 2024

biologics and money | Image credit: gopixa - stock.adobe.com
Study: More Biosimilar Competition Is Not Lowering Patient OOP Costs

March 29th 2024

Video Series
Video Interviews
CFB podcast banner
CFB podcas
CFB podcast banner
CFB podcast banner
cfb podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
"When Choice Arrives: Competition & Consequences" written over a bright blue syringe with the AJMC/The Center for Biosimilars logo in the bottom right corner
podcast banner
Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.